CELG Forum Topics
- All Comments on CELG
- General Discussion on CELG
- Poniard Pharmaceuticals: Platinum Rediscovered (Part II) [view article]
- Roche's Genentech Offer Sends Ripples Through Biotech [view article]
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF [view article]
- Bargain Hunting: Stocks With Strong Earnings Growth [view article]
- Oncology Conference Countdown: What Will Pharma and Biotech Companies Report? [view article]
- Big Biotech Booms But IBB Falls Flat [view article]
- Financials Down Market - Fast Money Recap (7/11/08) [view article]
- Take a Load Off Fannie - Fast Money Recap (7/10/08) [view article]
- GM an Unlikely Hero - Fast Money Recap (7/1/08) [view article]
- Celgene Corp. Q1 2008 Earnings Call Transcript [view article]
- Commodities Cool Off - Fast Money Recap (7/7/08) [view article]
- GM on the Skids - Fast Money Recap (7/2/08) [view article]
Recent CELG Articles
- Earnings Preview: Celgene Corporation
- Roche's Genentech Offer Sends Ripples Through Biotech
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF
- Big Biotech Booms But IBB Falls Flat
- Do Tell, Intel - Fast Money Recap (7/15/08)
- Financials Down Market - Fast Money Recap (7/11/08)
- Take a Load Off Fannie - Fast Money Recap (7/10/08)
- Pfizer, Merck and Lilly Partner to Get "Enlightened"
- S&P's Poor Standard - Fast Money Recap (7/9/08)
- Commodities Cool Off - Fast Money Recap (7/7/08)
- Full List of Articles »
loading ...
Poniard Pharmaceuticals: Platinum Rediscovered (Part II) [view article]
Indeed, I am very bullish on EXEL. I don't have any writeups on them, maybe later this year, if I have the time.EXEL has so many shots on goal, with an excellent strategy of focusing on niche markets first, so the risk/reward ratio is quite compelling. Reply
Poniard Pharmaceuticals: Platinum Rediscovered (Part II) [view article]
I see you are long EXEL. Do you have any writeup on this company ReplyRoche's Genentech Offer Sends Ripples Through Biotech [view article]
If Roche versus DNA doesn't progress, expect professional dweeb carl Icahn to come in and stamp his feet, and pound his fists, and hold his breath until some under-worked reporter converts his simple-minded proposals into a quick headline. ReplyMonday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF [view article]
Saw that the housing sector was the big winner last week and did a little more research on it. This article (www.greenfaucet.com/fa...) argues that housing may finally have reached a bottom. Check it out if you're interested in buying. ReplyTiedeman
Bargain Hunting: Stocks With Strong Earnings Growth [view article]
Titanium Metals Corporation produces titanium melted and mill products. It offers titanium sponge, which is the basic form of titanium metal used in titanium products; and melted products, such as ingot, electrodes, and slab that are the result of melting sponge and titanium scrap. The company also provides mill products that are forged and rolled from ingot or slab products, including billets, bars, plates, sheets and strips, and pipes; and fabrications, which comprise spools, pipe fittings, manifolds, and vessels that are cut, formed, welded, and assembled from titanium mill products. Titanium Metals Corporation sells its products directly in the United States and Europe, as well as through independent agents and distributors worldwide. It serves commercial aerospace and military, chemical process, oil and gas, consumer, sporting goods, automotive, and power generation sectors. The company was founded in 1950 and is headquartered in Dallas, Texas ReplyOncology Conference Countdown: What Will Pharma and Biotech Companies Report? [view article]
Dear Dr. Norman Lepoff,I am a retired Principal Biochemist and recognized expert in carbohydrate chemistry with 5 US Patents. I have worked out a novel anti-cancer therapy that I would like to discuss with you in private rather than in a public forum. Can you send me your private contact information for a confidential yet thorough discussion? I think that you will be impressed. I ultimately hope to obtain from you the names of contact individuals in oncological research, preferably at the big pharmaceutical houses.
Thank you,
Robert J. Mizerak
(Oconomowoc, WI)
Reply
Big Biotech Booms But IBB Falls Flat [view article]
IBB is up over .80 today, you call that flat??? ReplyFinancials Down Market - Fast Money Recap (7/11/08) [view article]
i to like pde i think it is a great stock i will buy more pde on pull back i hold thousands of shares now finerman you have a good call go longthanks Reply
Financials Down Market - Fast Money Recap (7/11/08) [view article]
Sell Bud was a great call.Luckily,most didn't have time to act on that piece of brilliance.. ReplyTake a Load Off Fannie - Fast Money Recap (7/10/08) [view article]
Good post! Fanny Mae and Freddy Mac executives should go to prision for the 10 trillion dollar rip off of America....or what is left of it.On Jul 12 10:41 AM Ames Tiedeman wrote:
> The US housing sector will remain depressed for the next 10 years,
> not the next 10 months. Reply
It
Bargain Hunting: Stocks With Strong Earnings Growth [view article]
Ames, what do you know about TIE. Why do you like it? Boon Pickens ones less than 1% of the stock.Reply
Tiedeman
Take a Load Off Fannie - Fast Money Recap (7/10/08) [view article]
The US housing sector will remain depressed for the next 10 years, not the next 10 months. ReplyTiedeman
GM an Unlikely Hero - Fast Money Recap (7/1/08) [view article]
All of this crap is going lower. ReplyTake a Load Off Fannie - Fast Money Recap (7/10/08) [view article]
Fanny and Freddy with 200 over compensated bureaucrats as "over_sight" watch dogs ran up 10 trillion eigh hundred billion in debt for the dumb people in this country to pay off. Why do we think our government can solve our problems when their own house is in shambles? Anybody with a brain has seen this coming. ReplyTiedeman
Bargain Hunting: Stocks With Strong Earnings Growth [view article]
TIE has been decimated. She will rise again. Boone Pickens owns this name Reply